Genetic Technologies Limited (GTG) is diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The Company's lead product is BREVAGenplus. In May 2019, the Company announced that it had developed two new cancer risk assessment tests branded as ‘GeneType for Colorectal Cancer' and ‘GeneType for Breast Cancer'
Genetic Technologies
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEW ROLE: Carl Stubbings, | 03 Nov 2022 | |
NEW ROLE: Kevin Camilleri, | 03 Nov 2022 | |
NEW ROLE: Michael Tonroe, Chief Financial Officer | 16 Feb 2022 | |
NEW ROLE: Chris Saunders, | 24 Nov 2020 | |
NEW ROLE: Diana Newport, | 24 Nov 2020 | |
NEW ROLE: Stanley Sack, Chief Operating Officer | 24 Nov 2020 | |
NEW ROLE: Kevin Fischer, Chief Financial Officer | 24 Nov 2020 | |
NEW ROLE: Paul Viney, Director | 24 Nov 2020 | |
NEW ROLE: Susan Gross, | 24 Nov 2020 |